Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Oncology Institute (TOI) Leases (2022 - 2025)

Oncology Institute's Leases history spans 4 years, with the latest figure at $22.4 million for Q4 2025.

  • For Q4 2025, Leases fell 13.22% year-over-year to $22.4 million; the TTM value through Dec 2025 reached $22.4 million, down 13.22%, while the annual FY2025 figure was $22.4 million, 13.22% down from the prior year.
  • Leases reached $22.4 million in Q4 2025 per TOI's latest filing, down from $23.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $29.2 million in Q4 2023 to a low of $17.2 million in Q1 2022.
  • Average Leases over 4 years is $24.8 million, with a median of $24.7 million recorded in 2022.
  • Peak YoY movement for Leases: skyrocketed 68.3% in 2023, then fell 14.1% in 2025.
  • A 4-year view of Leases shows it stood at $24.5 million in 2022, then grew by 19.09% to $29.2 million in 2023, then dropped by 11.61% to $25.8 million in 2024, then dropped by 13.22% to $22.4 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Leases are $22.4 million (Q4 2025), $23.3 million (Q3 2025), and $23.9 million (Q2 2025).